Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride is more effective than finasteride in reducing urinary retention and surgery risks in people aged 65 and older.

Testosterone replacement therapy improved blood sugar and fat levels without raising prostate cancer risk in Japanese men with low testosterone.

5-α-reductase inhibitors don't prevent prostate cancer but may reduce unnecessary biopsies.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

Case-only trees and random forests improve predictions of treatment effects in clinical trials.

Tissue expansion for head and neck reconstruction has good blood supply and doesn't need capsule removal, but expect temporary hair loss with normal growth resuming after 6-8 months.

Finasteride significantly reduces fertility in male rats.

Higher urethral PSA levels after prostate removal may be linked to more scalp hair loss and more PSA in urethral glands.

Male hormones may make COVID-19 worse, while substances that block these hormones could lessen symptoms.

A new mutation linked to partial Androgen Insensitivity Syndrome and prostate cancer was found in a patient unhappy with their female gender assignment.

Connarus semidecandrus Jack extract promotes hair growth and thickness, reduces prostate cancer cell growth, and could potentially be used as a treatment for hair loss.

Androgen deprivation therapy might help prevent severe COVID-19, but more research is needed.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

The conclusion is that tritium-labeled testosterone metabolites can be made and are better converted into dihydrotestosterone in skin cells than in prostate tissue.

Certain interactions help prepare the androgen receptor for pairing and activation, which is important for its role in development and disease.

Androgen levels can increase at any age, affecting symptoms like acne, hair loss, and prostate size.

Finasteride treats hair loss but may cause side effects like low libido and dizziness.

Finasteride reduces low-grade prostate cancer but may not be beneficial overall.

Testosterone changes reduce thyroxin levels in rats.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Male pattern baldness is common, treatable, and may be linked to heart disease and prostate cancer.

Finasteride effectively slowed hair loss and promoted hair growth in Taiwanese men.

Finasteride reduces sperm count and affects male reproductive function, while Epristeride does not.

Cyproterone acetate may cause liver cancer at high doses, but is considered safe at recommended doses for approved uses.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

Early hair loss may signal a risk for metabolic syndrome and related health issues.

Androgenetic alopecia may indicate higher risk for certain diseases and mental health issues.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

The research gives new understanding on how human steroid 5α-reductases work and how drugs like finasteride inhibit them, which could help in creating new drugs.